EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrated surveillance in Kilifi reveals continued SARS-CoV-2 circulation and immune escape of emerging JN.1 sublineages post-pandemic

Gloria Konyino, Bernadette Kutima, Sharon Owuor, Donwilliams Omuoyo, Gerald Waweru, Igor Andrade Santos, Arnold W Lambisia, Esther Nyadzua Katama, Angela Maina, Joyce Uche Nyiro, Charles Agoti, Charles Sande und 7 weitere

Frontiers in Cellular and Infection Microbiology · 2026

DOI: 10.3389/fcimb.2026.1910106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Gloria Konyino und 18 weiteren Autor:innen. Beteiligte Einrichtung: KEMRI-Wellcome Trust Research Programme, Center for Geographic Medicine Research, Coast, Kilifi, Kilifi County, Kenya. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Immune Evasion. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

SARS-CoV-2 has been deprioritized post-pandemic, especially in Africa. Vaccination in Kenya was conducted using the Wuhan-based vaccines only, which showed reduced neutralization efficacy against Omicron and its sublineages.

Methods

We performed SARS-CoV-2 immune surveillance in five health facilities within the Kilifi Health Demographic and Surveillance System from November 2024 to March 2026. Patients in the facilities presenting acute respiratory symptoms were recruited and nasopharyngeal/oropharyngeal swabs taken for SARS-CoV-2 RT-PCR. Convalescent plasma from 30 patients with confirmed SARS-CoV-2 RT-PCR positive tests and genome sequences were taken for sero-neutralization assays against the infecting variants LF.7, MV.1, and globally predominant strains, XEC.4, LP.8.1 and XFG.

Results

In total 5115 patients were tested and 171 patients (3.4%) were positive for SARS-CoV-2. Cough (91.7%), nasal discharge (74.5%) and fever (55.4%) were the most common symptoms while wheezing (2%) and crackles (2.8%) were rarest. Sequencing revealed circulation of JN.1 omicron sub-lineages, LF.7, MV.1 and XEF. Sera from majority of individuals infected by the dominant variants, LF.7 and MV.1 were able to neutralize infecting variants but not the recently circulating XFG variant 23% (7/30) suggesting that infection with a JN.1 lineage virus alone is not sufficient to prevent re-infection with XFG. Overlapping titer distributions was observed between vaccinated and unvaccinated sera, with no statistically significant difference observed for any variant.

Conclusion

Our study demonstrates that SARS-CoV-2 continues to circulate in coastal Kenya causing predominantly mild upper respiratory illness while evolution enabling immune escape. These findings emphasize the importance of integrated genomic and immunological surveillance to track emerging variants, evaluate population-level protection, and inform future vaccine update strategies and public health preparedness efforts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19Immune EvasionHumansKenyaFemaleMaleAdultAntibodies, ViralMiddle AgedAntibodies, NeutralizingYoung AdultAgedAdolescentCOVID-19 VaccinesPandemicsChild

Stichwörter der Autor:innen

JN.1 sub-lineagesSARS-CoV-2immune escapelow middle income countriesneutralizing antibodiessub-Saharan Africaviral evolutionwhole genome sequencing

Substanzen

Antibodies, ViralAntibodies, NeutralizingCOVID-19 Vaccines

Autor:innen und Institutionen

  • KEMRI-Wellcome Trust Research Programme, Center for Geographic Medicine Research, Coast, Kilifi, Kilifi County, Kenya.
  • Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.
  • Viral Glycoproteins Group, The Pirbright Institute, Pirbright, United Kingdom.
  • Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom.

Förderung

  • Wellcome Trust

Zitieren

APA

Konyino, G., Kutima, B., Owuor, S., Omuoyo, D., Waweru, G., Santos, I. A., Lambisia, A. W., Katama, E. N., Maina, A., Nyiro, J. U., Agoti, C., Sande, C., Bejon, P., Bailey, D., Warimwe, G. M., Ochola-Oyier, L. I., Lugano, D., Nyanjom, S. G., & Nyagwange, J. (2026). Integrated surveillance in Kilifi reveals continued SARS-CoV-2 circulation and immune escape of emerging JN.1 sublineages post-pandemic. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1910106

Vancouver

Konyino G, Kutima B, Owuor S, Omuoyo D, Waweru G, Santos IA, et al. Integrated surveillance in Kilifi reveals continued SARS-CoV-2 circulation and immune escape of emerging JN.1 sublineages post-pandemic. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1910106

BibTeX
@article{Konyino2026,
  author = {Konyino, Gloria and Kutima, Bernadette and Owuor, Sharon and Omuoyo, Donwilliams and Waweru, Gerald and Santos, Igor Andrade and Lambisia, Arnold W and Katama, Esther Nyadzua and Maina, Angela and Nyiro, Joyce Uche and Agoti, Charles and Sande, Charles and Bejon, Philip and Bailey, Dalan and Warimwe, George Mbugua and Ochola-Oyier, L Isabella and Lugano, Doreen and Nyanjom, Steven Ger and Nyagwange, James},
  title = {Integrated surveillance in Kilifi reveals continued SARS-CoV-2 circulation and immune escape of emerging JN.1 sublineages post-pandemic},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  doi = {10.3389/fcimb.2026.1910106}
}
Kostenlos starten →